Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Spontaneous remission of post-transplant recurrent focal and segmental glomerulosclerosis.

Saeed B, Mazloum H, Askar M.

Saudi J Kidney Dis Transpl. 2011 Nov;22(6):1219-22.

2.

Recurrent focal glomerulosclerosis: natural history and response to therapy.

Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F.

Am J Med. 1992 Apr;92(4):375-83.

PMID:
1558084
3.

Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports.

Fencl F, Simková E, Vondrák K, Janda J, Chadimová M, Stejskal J, Seeman T.

Transplant Proc. 2007 Dec;39(10):3488-90.

PMID:
18089416
4.

Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.

Rodríguez-Ferrero M, Ampuero J, Anaya F.

Transplant Proc. 2009 Jul-Aug;41(6):2406-8. doi: 10.1016/j.transproceed.2009.06.044.

PMID:
19715934
5.

Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience.

Hubsch H, Montané B, Abitbol C, Chandar J, Shariatmadar S, Ciancio G, Burke G, Miller J, Strauss J, Zilleruelo G.

Pediatr Nephrol. 2005 Feb;20(2):210-6. Epub 2004 Dec 17.

PMID:
15605284
6.

Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose.

Chishti AS, Sorof JM, Brewer ED, Kale AS.

Am J Kidney Dis. 2001 Oct;38(4):754-60.

PMID:
11576878
7.

Plasmapheresis for recurrent posttransplant focal segmental glomerulosclerosis.

Garcia CD, Bittencourt VB, Tumelero A, Antonello JS, Malheiros D, Garcia VD.

Transplant Proc. 2006 Jul-Aug;38(6):1904-5.

PMID:
16908318
8.

Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients.

Matalon A, Markowitz GS, Joseph RE, Cohen DJ, Saal SD, Kaplan B, D'Agati VD, Appel GB.

Clin Nephrol. 2001 Oct;56(4):271-8.

PMID:
11680656
9.

Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children.

Dall'Amico R, Ghiggeri G, Carraro M, Artero M, Ghio L, Zamorani E, Zennaro C, Basile G, Montini G, Rivabella L, Cardillo M, Scalamogna M, Ginevri F.

Am J Kidney Dis. 1999 Dec;34(6):1048-55.

PMID:
10585314
10.

Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.

Gossmann J, Scheuermann EH, Porubsky S, Kachel HG, Geiger H, Hauser IA.

Transpl Int. 2007 Jun;20(6):558-62. Epub 2007 Apr 13.

11.

High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children.

Raafat RH, Kalia A, Travis LB, Diven SC.

Am J Kidney Dis. 2004 Jul;44(1):50-6.

PMID:
15211437
12.

Long-term outcome of focal segmental glomerulosclerosis after pediatric renal transplantation.

Fuentes GM, Meseguer CG, Carrion AP, Hijosa MM, Garcia-Pose A, Melgar AA, Torres MN.

Pediatr Nephrol. 2010 Mar;25(3):529-34. doi: 10.1007/s00467-009-1361-0. Epub 2009 Dec 3.

PMID:
19956977
13.

Focal segmental glomerulosclerosis and renal transplantation.

Crosson JT.

Transplant Proc. 2007 Apr;39(3):737-43. Review.

PMID:
17445586
14.

Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients.

Straatmann C, Kallash M, Killackey M, Iorember F, Aviles D, Bamgbola O, Carson T, Florman S, Vehaskari MV.

Pediatr Transplant. 2014 Feb;18(1):29-34. doi: 10.1111/petr.12185. Epub 2013 Nov 25.

PMID:
24266922
15.

Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation.

Freiberger V, Amann K, Heemann U, Frank H.

Transpl Int. 2009 Nov;22(11):1110-3. doi: 10.1111/j.1432-2277.2009.00897.x. Epub 2009 May 20.

16.

Early use of plasmapheresis for recurrent post-transplant FSGS.

Pradhan M, Petro J, Palmer J, Meyers K, Baluarte HJ.

Pediatr Nephrol. 2003 Sep;18(9):934-8. Epub 2003 Jun 26.

PMID:
12836097
17.

Preemptive plasmapheresis and recurrence of focal segmental glomerulosclerosis in pediatric renal transplantation.

Gonzalez E, Ettenger R, Rianthavorn P, Tsai E, Malekzadeh M.

Pediatr Transplant. 2011 Aug;15(5):495-501. doi: 10.1111/j.1399-3046.2011.01478.x. Epub 2011 Feb 21.

PMID:
21338460
18.

Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients.

Gohh RY, Yango AF, Morrissey PE, Monaco AP, Gautam A, Sharma M, McCarthy ET, Savin VJ.

Am J Transplant. 2005 Dec;5(12):2907-12.

19.

Double recurrence of FSGS after two renal transplants with complete regression after plasmapheresis and ACE inhibitors.

Montagnino G, Tarantino A, Banfi G, Maccario M, Costamagna L, Ponticelli C.

Transpl Int. 2000;13(2):166-8.

20.

Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis.

Yabu JM, Ho B, Scandling JD, Vincenti F.

Am J Transplant. 2008 Jan;8(1):222-7. Epub 2007 Nov 2.

Items per page

Supplemental Content

Write to the Help Desk